Endo's Patent Loss Over Blood Pressure Drug Adds to Its Troubles

11:29am PDT - August 31st, 2021    eagles - Bloomberg

Endo International Plc’s loss in a patent fight over its bestselling blood pressure drug comes at a tough time for the company, as it grapples with opioid lawsuits and weighs a debt restructuring.